Navamedic ASA
XBER:N1A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Navamedic ASA
XBER:N1A
|
NO |
|
EQT AB
STO:EQT
|
SE |
|
J
|
Jasa Marga (Persero) Tbk PT
XBER:0JM
|
ID |
|
C
|
CSPC Pharmaceutical Group Ltd
SWB:CVG
|
CN |
|
CleanGo Innovations Inc
F:APO
|
CA |
|
D
|
Douglas Dynamics Inc
XBER:5D4
|
US |
Wall St Price Targets
N1A Price Targets Summary
Navamedic ASA
According to Wall Street analysts, the average 1-year price target for N1A is 2.897 EUR with a low forecast of 2.868 EUR and a high forecast of 2.982 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is N1A's stock price target?
Price Target
2.897
EUR
According to Wall Street analysts, the average 1-year price target for N1A is 2.897 EUR with a low forecast of 2.868 EUR and a high forecast of 2.982 EUR.
What is the Revenue forecast for Navamedic ASA?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 8 years is 7%.
What is the Operating Income forecast for Navamedic ASA?
Projected CAGR
30%
The compound annual growth rate for Operating Income over the next 8 years is 30%.
